On February 2, 2026, UBS reiterated its bullish stance on Intel with a price target implying roughly a 7.2% upside from recent levels. The shares rallied by just over 3% that day as investors weighed the firm’s data center and client commitments. Intraday trading demonstrated significant volatility, with the stock oscillating across a multi‐dollar range, reflecting shifting risk appetites in the broader tech sector.

Despite a high‐profile government injection of nine billion dollars to bolster domestic chipmaking, Intel has faced consecutive quarters of year‐over‐year revenue declines and repeatedly pushed back the opening timelines of its most advanced fabrication facilities. These delays have tested investor patience, particularly as competitors ramp production and capture market share in both PC and data center chips.

Intel’s long‐term turnaround hinges on syncing volume production of its 18A process with robust 14A client demand through 2026 and 2027. This alignment marks a potential inflection point for Intel’s foundry ambition, as it seeks to restore credibility in its ability to deliver cutting‐edge nodes. Successful ramp of 18A would not only underpin margin expansion but also position Intel as a more formidable alternative to third‐party foundries.